FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030546890> ?p ?o ?g. }

• W2030546890 endingPage "2176" @default.
• W2030546890 startingPage "2168" @default.
• W2030546890 abstract "OBJECTIVE Compare the efficacy and safety of monotherapy with dulaglutide, a once-weekly GLP-1 receptor agonist, to metformin-treated patients with type 2 diabetes. The primary objective compared dulaglutide 1.5 mg and metformin on change from baseline glycosylated hemoglobin A1c (HbA1c) at 26 weeks. RESEARCH DESIGN AND METHODS This 52-week double-blind study randomized patients to subcutaneous dulaglutide 1.5 mg, dulaglutide 0.75 mg, or metformin. Patients (N = 807) had HbA1c ≥6.5% (≥48 mmol/mol) and ≤9.5% (≤80 mmol/mol) with diet and exercise alone or low-dose oral antihyperglycemic medication (OAM) monotherapy; OAMs were discontinued at beginning of lead-in period. RESULTS At 26 weeks, changes from baseline HbA1c (least squares [LS] mean ± SE) were: dulaglutide 1.5 mg, −0.78 ± 0.06% (−8.5 ± 0.70 mmol/mol); dulaglutide 0.75 mg, −0.71 ± 0.06% (−7.8 ± 0.70 mmol/mol); and metformin, −0.56 ± 0.06% (−6.1 ± 0.70 mmol/mol). Dulaglutide 1.5 and 0.75 mg were superior to metformin (LS mean difference): −0.22% (−2.4 mmol/mol) and −0.15% (−1.6 mmol/mol) (one-sided P &lt; 0.025, both comparisons), respectively. Greater percentages reached HbA1c targets &lt;7.0% (&lt;53 mmol/mol) and ≤6.5% (≤48 mmol/mol) with dulaglutide 1.5 and 0.75 mg compared with metformin (P &lt; 0.05, all comparisons). No severe hypoglycemia was reported. Compared with metformin, decrease in weight was similar with dulaglutide 1.5 mg and smaller with dulaglutide 0.75 mg. Over 52 weeks, nausea, diarrhea, and vomiting were the most common adverse events; incidences were similar between dulaglutide and metformin. CONCLUSIONS Dulaglutide improves glycemic control and is well tolerated as monotherapy in patients with early stage type 2 diabetes." @default.
• W2030546890 created "2016-06-24" @default.
• W2030546890 creator A5037602130 @default.
• W2030546890 creator A5037842574 @default.
• W2030546890 creator A5042706567 @default.
• W2030546890 creator A5061058170 @default.
• W2030546890 creator A5089497324 @default.
• W2030546890 date "2014-07-12" @default.
• W2030546890 modified "2023-10-16" @default.
• W2030546890 title "Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)" @default.
• W2030546890 cites W1966469183 @default.
• W2030546890 cites W1968499323 @default.
• W2030546890 cites W1972057139 @default.
• W2030546890 cites W2013082477 @default.
• W2030546890 cites W2025995365 @default.
• W2030546890 cites W2027804378 @default.
• W2030546890 cites W2042129134 @default.
• W2030546890 cites W2043900831 @default.
• W2030546890 cites W2064437324 @default.
• W2030546890 cites W2072691447 @default.
• W2030546890 cites W2084943874 @default.
• W2030546890 cites W2098459806 @default.
• W2030546890 cites W2108106161 @default.
• W2030546890 cites W2109677274 @default.
• W2030546890 cites W2126065052 @default.
• W2030546890 cites W2139485303 @default.
• W2030546890 cites W2145823132 @default.
• W2030546890 cites W2147817624 @default.
• W2030546890 cites W2151848850 @default.
• W2030546890 cites W2159198773 @default.
• W2030546890 cites W2160274347 @default.
• W2030546890 cites W2171667655 @default.
• W2030546890 cites W2172193326 @default.
• W2030546890 cites W2190748907 @default.
• W2030546890 cites W2325963726 @default.
• W2030546890 cites W4245367233 @default.
• W2030546890 cites W4292528167 @default.
• W2030546890 doi "https://doi.org/10.2337/dc13-2759" @default.
• W2030546890 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24842985" @default.
• W2030546890 hasPublicationYear "2014" @default.
• W2030546890 type Work @default.
• W2030546890 sameAs 2030546890 @default.
• W2030546890 citedByCount "247" @default.
• W2030546890 countsByYear W20305468902014 @default.
• W2030546890 countsByYear W20305468902015 @default.
• W2030546890 countsByYear W20305468902016 @default.
• W2030546890 countsByYear W20305468902017 @default.
• W2030546890 countsByYear W20305468902018 @default.
• W2030546890 countsByYear W20305468902019 @default.
• W2030546890 countsByYear W20305468902020 @default.
• W2030546890 countsByYear W20305468902021 @default.
• W2030546890 countsByYear W20305468902022 @default.
• W2030546890 countsByYear W20305468902023 @default.
• W2030546890 crossrefType "journal-article" @default.
• W2030546890 hasAuthorship W2030546890A5037602130 @default.
• W2030546890 hasAuthorship W2030546890A5037842574 @default.
• W2030546890 hasAuthorship W2030546890A5042706567 @default.
• W2030546890 hasAuthorship W2030546890A5061058170 @default.
• W2030546890 hasAuthorship W2030546890A5089497324 @default.
• W2030546890 hasBestOaLocation W20305468901 @default.
• W2030546890 hasConcept C126322002 @default.
• W2030546890 hasConcept C126894567 @default.
• W2030546890 hasConcept C134018914 @default.
• W2030546890 hasConcept C2777180221 @default.
• W2030546890 hasConcept C2779829264 @default.
• W2030546890 hasConcept C2780323712 @default.
• W2030546890 hasConcept C2780533449 @default.
• W2030546890 hasConcept C2780668416 @default.
• W2030546890 hasConcept C555293320 @default.
• W2030546890 hasConcept C71924100 @default.
• W2030546890 hasConcept C90924648 @default.
• W2030546890 hasConceptScore W2030546890C126322002 @default.
• W2030546890 hasConceptScore W2030546890C126894567 @default.
• W2030546890 hasConceptScore W2030546890C134018914 @default.
• W2030546890 hasConceptScore W2030546890C2777180221 @default.
• W2030546890 hasConceptScore W2030546890C2779829264 @default.
• W2030546890 hasConceptScore W2030546890C2780323712 @default.
• W2030546890 hasConceptScore W2030546890C2780533449 @default.
• W2030546890 hasConceptScore W2030546890C2780668416 @default.
• W2030546890 hasConceptScore W2030546890C555293320 @default.
• W2030546890 hasConceptScore W2030546890C71924100 @default.
• W2030546890 hasConceptScore W2030546890C90924648 @default.
• W2030546890 hasIssue "8" @default.
• W2030546890 hasLocation W20305468901 @default.
• W2030546890 hasLocation W20305468902 @default.
• W2030546890 hasOpenAccess W2030546890 @default.
• W2030546890 hasPrimaryLocation W20305468901 @default.
• W2030546890 hasRelatedWork W2005084305 @default.
• W2030546890 hasRelatedWork W2033313326 @default.
• W2030546890 hasRelatedWork W2057434408 @default.
• W2030546890 hasRelatedWork W2070732543 @default.
• W2030546890 hasRelatedWork W2072752555 @default.
• W2030546890 hasRelatedWork W2076974163 @default.
• W2030546890 hasRelatedWork W2092734860 @default.
• W2030546890 hasRelatedWork W2107068945 @default.
• W2030546890 hasRelatedWork W2121663374 @default.
• W2030546890 hasRelatedWork W2744240433 @default.
• W2030546890 hasVolume "37" @default.

• next